The treatment of Alzheimer disease has continued to develop during the past decade. Although an acetylcholine esterase (AchE) inhibitor has been widely used for the treatment of cognitive function in patients with Alzheimer disease through an enhancement of cholinergic function, an open-channel blockade agent targeted for N-methyl-d-aspartate (NMDA) has recently been established as a novel treatment of Alzheimer disease, namely, memantine. Memantine reduced clinical deterioration in moderate-to-severe Alzheimer disease.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2sgmROL
from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sg7XIq
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,